Makoto Tsuneoka

Affiliation and department：

Research keywords (5)： cell proliferation , histone methyl transferase , histone demethylase , chromatin , ribosome

Papers (31)：

Yuji Tanaka, Akimitsu Konishi, Hideru Obinata, Makoto Tsuneoka. Metformin activates KDM2A to reduce rRNA transcription and cell proliferation by dual regulation of AMPK activity and intracellular succinate level. Scientific Reports. 2019. in press. 1. 18694
Okamoto K, Tanaka Y, Ogasawara S, Obuse C, Nakayama JI, Yano H, Tsuneoka M. KDM2A-dependent reduction of rRNA transcription on glucose starvation requires HP1 in cells, including triple-negative breast cancer cells. Oncotarget. 2019. 10. 46. 4743-4760
Yuji Tanaka, Makoto Tsuneoka. Control of Ribosomal RNA Transcription by Nutrients. Book title: "Gene Expression and Regulation in Mammalian Cells - Transcription Toward the Establishment of Novel Therapeutics" published by InTech - open science,. 2018. Chapter 2. 25-52
Kengo Okamoto, Yuji Tanaka, Makoto Tsuneoka. SF-KDM2A binds to ribosomal RNA gene promoter, reduces H4K20me3 level, and elevates ribosomal RNA transcription in breast cancer cells. INTERNATIONAL JOURNAL OF ONCOLOGY. 2017. 50. 4. 1372-1382
Komiya K, Sueoka-Aragane N, Sato A, Hisatomi T, Sakuragi T, Mitsuoka M, Sato T, Hayashi S, Izumi H, Tsuneoka M, et al. Erratum to "Expression of Mina53, a novel c-Myc target gene, is a favorable prognostic marker in early stage lung cancer" [Lung Cancer 69/2 (2010) 232-238]. Lung cancer (Amsterdam, Netherlands). 2016. 101. 148

ｍore...

Books (6)：

ｍore...

※ Researcher’s information displayed in J-GLOBAL is based on the information registered in researchmap. For details, see here.

Return to Previous Page